In a study by Suzuki et al. [91], the 211At‐labeled PSMA derivative ([211At]16) demonstrated low accumulation in the stomach (1.74 ± 0.39 %ID/g) and thyroid (0.55 ± 0.33 %ID/g) in tumor‐bearing mice 3 h postinjection. Here, FOLH1 is linked to neoplasm.